IL6 and COVID-19: In fact, previous studies also showed severity of COVID-19 is associated with increased levels of inflammatory proteins (interleukin 6) [51], coagulation proteins (VWF [52] and fibrinogen [53]), but a specific link with development of thromboembolic outcome could not be found [49].